Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype.


Journal

Hamostaseologie
ISSN: 2567-5761
Titre abrégé: Hamostaseologie
Pays: Germany
ID NLM: 8204531

Informations de publication

Date de publication:
Oct 2022
Historique:
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 29 10 2022
Statut: ppublish

Résumé

Coronavirus disease-2019 (COVID-19) is associated with increased thromboembolic complications. Long-term alteration in

Identifiants

pubmed: 36288732
doi: 10.1055/a-1797-0564
doi:

Substances chimiques

Phosphatidylserines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S14-S23

Subventions

Organisme : BA5158/4
ID : German Research Foundation and from the Herzstiftung

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

T.B. has received research funding from CoaChrom Diagnostica GmbH, DFG, Robert Bosch GmbH, Stiftung Transfusionsmedizin und Immunhämatologie e.V.: Ergomed, DRK Blutspendedienst, Deutsche Herzstiftung, Ministerium für Wissenschaft, Forschung und Kunst Baden-Wuerttemberg; has received lecture honoraria from Aspen Germany GmbH, Bayer Vital GmbH, Bristol-Myers Squibb GmbH & Co., Doctrina Med AG, Meet The Experts Academy UG, Schoechl Medical Education GmbH, Stago GmbH, Mitsubishi Tanabe Pharma GmbH, Novo Nordisk Pharma GmbH, Leo Pharma GmbH, Swedish Orphan Biovitrum GmbH; has provided consulting services to Terumo; has provided expert witness testimony relating to heparin-induced thrombocytopenia (HIT) and non-HIT thrombocytopenic and coagulopathic disorders. All of these are outside the current work. Other authors declare no competing financial interests.

Auteurs

Günalp Uzun (G)

Centre for Clinical Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany.

Anurag Singh (A)

Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tübingen, University Hospital of Tübingen, Tübingen, Germany.

Wissam Abou-Khalel (W)

Centre for Clinical Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany.

Lisann Pelzl (L)

Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tübingen, University Hospital of Tübingen, Tübingen, Germany.

Karoline Weich (K)

Centre for Clinical Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany.

Stefanie Nowak-Harnau (S)

Centre for Clinical Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany.

Karina Althaus (K)

Centre for Clinical Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany.
Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tübingen, University Hospital of Tübingen, Tübingen, Germany.

Peter Bugert (P)

Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Hessen, Mannheim, Germany.

Harald Klüter (H)

Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Hessen, Mannheim, Germany.

Tamam Bakchoul (T)

Centre for Clinical Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany.
Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tübingen, University Hospital of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH